Sunshine Act Meetings, 31347-31348 [2021-12449]
Download as PDF
Federal Register / Vol. 86, No. 111 / Friday, June 11, 2021 / Notices
You may obtain publicly available
information related to this document
using any of the following methods:
• Federal Rulemaking Website: Go to
https://www.regulations.gov and search
for Docket ID NRC–2019–0086. Address
questions about Docket IDs in
Regulations.gov to Stacy Schumann;
telephone: 301–415–0624; email:
Stacy.Schumann@nrc.gov. For technical
questions, contact the individuals listed
in the FOR FURTHER INFORMATION
CONTACT section of this document.
• NRC’s Agencywide Documents
Access and Management System
(ADAMS): You may obtain publicly
available documents online in the
ADAMS Public Documents collection at
https://www.nrc.gov/reading-rm/
adams.html. To begin the search, select
‘‘Begin Web-based ADAMS Search.’’ For
problems with ADAMS, please contact
the NRC’s Public Document Room (PDR)
reference staff at 1–800–397–4209, 301–
415–4737, or by email to pdr.resource@
nrc.gov. The ADAMS accession number
for each document referenced (if it is
available in ADAMS) is provided the
first time that it is mentioned in this
document.
• Attention: The PDR, where you may
examine and order copies of public
documents, is currently closed. You
may submit your request to the PDR via
email at pdr.resource@nrc.gov or call 1–
800–397–4209 or 301–415–4737,
between 8:00 a.m. and 4:00 p.m. (EST),
Monday through Friday, except Federal
holidays.
Revision 3 to RG 1.187 and the
regulatory analysis may be found in
ADAMS under Accession Nos.
ML21109A002 and ML19045A432,
respectively.
Regulatory guides are not
copyrighted, and NRC approval is not
required to reproduce them.
FOR FURTHER INFORMATION CONTACT:
Philip McKenna, Office of Nuclear
Reactor Regulation, telephone: 301–
415–0037, email: Philip.McKenna@
nrc.gov and Robert Roche-Rivera, Office
of Nuclear Regulatory Research,
telephone: 301–415–8113, email:
Robert.Roche-Rivera@nrc.gov. Both are
staff of the U.S. Nuclear Regulatory
Commission, Washington, DC 20555–
0001.
SUPPLEMENTARY INFORMATION:
jbell on DSKJLSW7X2PROD with NOTICES
I. Discussion
The NRC is issuing a revision in the
NRC’s ‘‘Regulatory Guide’’ series. This
series was developed to describe and
make available to the public information
regarding methods that are acceptable to
the NRC staff for implementing specific
parts of the agency’s regulations,
VerDate Sep<11>2014
19:14 Jun 10, 2021
Jkt 253001
techniques that the NRC staff uses in
evaluating specific issues or postulated
events, and data that the NRC staff
needs in its review of applications for
permits and licenses.
RG 1.187, Revision 3, ‘‘Guidance for
Implementation of 10 CFR 50.59,
‘Changes, Tests, and Experiments,’ ’’
addresses a clarification to the RG in
response to post-promulgation
comments on RG 1.187, Revision 2
(ADAMS Accession No. ML20125A730).
Specifically, this Revision (i.e., Revision
3) adds an additional clarification in
section C.2.e of the RG related to the
Human Factors Engineering screening
examples in NEI 96–07, Appendix D,
Revision 1, ‘‘Supplemental Guidance for
Application of 10 CFR 50.59 to Digital
Modifications,’’ (ADAMS Accession No.
ML20135H168), that discuss an increase
in response time.
II. Additional Information
Proposed Revision 2 of RG 1.187 was
issued with a temporary identification
of Draft Regulatory Guide (DG)–1356
(ADAMS Accession No. ML19045A435).
The NRC published a notice of the
availability of DG–1356 in the Federal
Register on May 30, 2019 (84 FR 25077)
for a 45-day public comment period.
The public comment period closed on
July 15, 2019. Public comments on DG–
1356 and the staff responses to the
public comments are available in
ADAMS under Accession No.
ML20125A729. Based on the public
comments, subsequent public meetings,
and revisions to NEI 96–07, Appendix
D, the NRC revised the proposed
Revision 2 of RG 1.187 and issued the
final Revision 2 on July 7, 2020 (85 FR
40696), with a 30-day postpromulgation public comment period.
Revision 2 of RG 1.187 endorsed NEI
96–07, Appendix D, Revision 1, as a
means for complying with the
requirements of section 50.59 of title 10
of the Code of Federal Regulations (10
CFR), ‘‘Changes, tests and experiments’’
when conducting digital
instrumentation and control (I&C)
modifications, with certain
clarifications. The post-promulgation
public comment period closed on
August 6, 2020. Post-promulgation
public comments on RG 1.187, Revision
2 and the staff responses to the postpromulgation public comments are
available under ADAMS under
Accession No. ML21109A001.
The NRC notes that a nonconcurrence on RG 1.187, Revision 2,
was submitted and entered the NonConcurrence Process (NCP) under
tracking number of NCP–2020–005. The
NCP form and attachments are available
PO 00000
Frm 00083
Fmt 4703
Sfmt 4703
31347
in ADAMS under Accession No.
ML20197A381.
III. Congressional Review Act
This RG is a rule as defined in the
Congressional Review Act (5 U.S.C.
801–808). However, the Office of
Management and Budget has not found
it to be a major rule as defined in the
Congressional Review Act.
IV. Backfitting, Forward Fitting, and
Issue Finality
Revision 3 of RG 1.187 provides
guidance on complying with the
requirements of 10 CFR 50.59 when
performing a digital I&C modification.
As explained in RG 1.187, Revision 3,
licensees are not required to comply
with the positions set forth in this
regulatory guide. Therefore, RG 1.187,
Revision 3, does not constitute
backfitting as defined in 10 CFR 50.109,
‘‘Backfitting,’’ and as described in NRC
Management Directive (MD) 8.4,
‘‘Management of Backfitting, Forward
Fitting, Issue Finality, and Information
Requests’’; constitute forward fitting as
that term is defined and described in
MD 8.4; or affect issue finality of any
approval issued under 10 CFR part 52,
‘‘Licenses, Certificates, and Approvals
for Nuclear Power Plants.’’ If, in the
future, the NRC were to impose a
position in this RG 1.187, Revision 3, in
a manner that would constitute
backfitting or forward fitting or affect
the issue finality for a part 52 approval,
then the NRC would address the
backfitting provision in 10 CFR 50.109,
the forward fitting provision of MD 8.4,
or the applicable issue finality provision
in part 52, respectively.
Dated: June 7, 2021.
For the Nuclear Regulatory Commission.
Meraj Rahimi,
Chief, Regulatory Guidance and Programs
Management Branch, Division of Engineering,
Office of Nuclear Regulatory Research.
[FR Doc. 2021–12280 Filed 6–10–21; 8:45 am]
BILLING CODE 7590–01–P
NUCLEAR REGULATORY
COMMISSION
[NRC–2021–0001]
Sunshine Act Meetings
Weeks of June 14, 21, 28,
July 5, 12, 19, 2021.
PLACE: Commissioners’ Conference
Room, 11555 Rockville Pike, Rockville,
Maryland.
STATUS: Public.
MATTERS TO BE CONSIDERED:
TIME AND DATE:
E:\FR\FM\11JNN1.SGM
11JNN1
31348
Federal Register / Vol. 86, No. 111 / Friday, June 11, 2021 / Notices
Week of June 14, 2021
There are no meetings scheduled for
the week of June 14, 2021.
Week of June 21, 2021—Tentative
Tuesday, June 22, 2021
9:00 a.m. Briefing on Transformation
at the NRC—Midyear Review
(Public Meeting); (Contact: Maria
Arribas-Colon: 301–415–6026)
Additional Information: Due to
COVID–19, there will be no physical
public attendance. The public is invited
to attend the Commission’s meeting live
by webcast at the Web address—https://
video.nrc.gov/.
Week of June 28, 2021—Tentative
There are no meetings scheduled for
the week of June 28, 2021.
Week of July 5, 2021—Tentative
There are no meetings scheduled for
the week of July 5, 2021.
Week of July 12, 2021—Tentative
There are no meetings scheduled for
the week of July 12, 2021.
Week of July 19, 2021—Tentative
There are no meetings scheduled for
the week of July 19, 2021.
jbell on DSKJLSW7X2PROD with NOTICES
CONTACT PERSON FOR MORE INFORMATION:
For more information or to verify the
status of meetings, contact Wesley Held
at 301–287–3591 or via email at
Wesley.Held@nrc.gov. The schedule for
Commission meetings is subject to
change on short notice.
The NRC Commission Meeting
Schedule can be found on the internet
at: https://www.nrc.gov/public-involve/
public-meetings/schedule.html.
The NRC provides reasonable
accommodation to individuals with
disabilities where appropriate. If you
need a reasonable accommodation to
participate in these public meetings or
need this meeting notice or the
transcript or other information from the
public meetings in another format (e.g.,
braille, large print), please notify Anne
Silk, NRC Disability Program Specialist,
at 301–287–0745, by videophone at
240–428–3217, or by email at
Anne.Silk@nrc.gov. Determinations on
requests for reasonable accommodation
will be made on a case-by-case basis.
Members of the public may request to
receive this information electronically.
If you would like to be added to the
distribution, please contact the Nuclear
Regulatory Commission, Office of the
Secretary, Washington, DC 20555, at
301–415–1969, or by email at
Wendy.Moore@nrc.gov or Tyesha.Bush@
nrc.gov.
VerDate Sep<11>2014
19:14 Jun 10, 2021
Jkt 253001
The NRC is holding the meetings
under the authority of the Government
in the Sunshine Act, 5 U.S.C. 552b.
Dated: June 9, 2021.
For the Nuclear Regulatory Commission.
Wesley W. Held,
Policy Coordinator, Office of the Secretary.
[FR Doc. 2021–12449 Filed 6–9–21; 4:15 pm]
BILLING CODE 7590–01–P
SECURITIES AND EXCHANGE
COMMISSION
[Release No. 34–92120; File No. SR–ICEEU–
2021–013]
Self-Regulatory Organizations; ICE
Clear Europe Limited; Notice of Filing
of Proposed Rule Change Relating to
the ICE Clear Europe Articles of
Association
June 7, 2021.
Pursuant to Section 19(b)(1) of the
Securities Exchange Act of 1934
(‘‘Act’’),1 and Rule 19b–4 thereunder,2
notice is hereby given that on May 25,
2021, ICE Clear Europe Limited (‘‘ICE
Clear Europe’’ or the ‘‘Clearing House’’)
filed with the Securities and Exchange
Commission (‘‘Commission’’) the
proposed rule changes described in
Items I, II and III below, which Items
have been prepared primarily by ICE
Clear Europe. The Commission is
publishing this notice to solicit
comments on the proposed rule change
from interested persons.
I. Clearing Agency’s Statement of the
Terms of Substance of the Proposed
Rule Change
ICE Clear Europe Limited (‘‘ICE Clear
Europe’’ or the ‘‘Clearing House’’)
proposes to modify its Articles of
Association (the ‘‘Articles’’). The
revisions would not involve any
changes to the ICE Clear Europe
Clearing Rules or Procedures.
II. Clearing Agency’s Statement of the
Purpose of, and Statutory Basis for, the
Proposed Rule Change
In its filing with the Commission, ICE
Clear Europe included statements
concerning the purpose of and basis for
the proposed rule change and discussed
any comments it received on the
proposed rule change. The text of these
statements may be examined at the
places specified in Item IV below. ICE
Clear Europe has prepared summaries,
set forth in sections (A), (B), and (C)
below, of the most significant aspects of
such statements.
1 15
2 17
PO 00000
U.S.C. 78s(b)(1).
CFR 240.19b–4.
Frm 00084
Fmt 4703
(A) Clearing Agency’s Statement of the
Purpose of, and Statutory Basis for, the
Proposed Rule Change, Security-Based
Swap Submission or Advance Notice
(a) Purpose
The purpose of the amendments is to
update the Articles to reflect certain
changes in the composition of the ICE
Clear Europe Board and the composition
and structure of Board committees, to
clarify certain director independence
standards, to clarify certain superquorum standards applicable to certain
actions relating to CDS clearing, to
revise certain provisions regarding
directors and to reflect the use of
gender-neutral language, as discussed in
more detail herein.
In article 3,3 definitions of certain
specific committees would be deleted,
including the Audit Committee, Board
Risk Committee, Compensation
Committee and Nomination Committee,
and the definition of Committee would
be revised to generally reference any
committee constituted by the Board
under the Articles. Although ICE Clear
Europe is not proposing to change its
current committee structure at this time,
it does not believe the committees need
to be defined in the Articles. Since the
Board is authorized to create, modify or
dissolve committees as it determines to
be appropriate, the amendments would
facilitate future changes to the
committee structure by the Board
without need to amend the Articles. The
definition of Product Risk Committee,
however, would not be removed from
the Articles because there are references
to this committee throughout the
Articles in light of certain specific
requirements relating to the CDS
Director.
In addition, the amendments would
modify certain other definitions,
including CDS Director, Committees,
Independent Director, Risk Committee
and Super-Quorum Matters. These
definitions would be updated as
follows:
• CDS Director—a sentence would be
added to the definition to clarify that
the CDS Director may also meet the
criteria required of an Independent
Director, however, for the avoidance of
doubt they will continue to be classified
only as a CDS Director.
• Independent Director—this
definition would be updated such that
instead of describing this person as
independent of the Company and of the
Clearing House (without further
definition of independence), the
definition would require the director to
3 References herein to the numbering of particular
articles will be to the articles as amended.
Sfmt 4703
E:\FR\FM\11JNN1.SGM
11JNN1
Agencies
[Federal Register Volume 86, Number 111 (Friday, June 11, 2021)]
[Notices]
[Pages 31347-31348]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-12449]
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
[NRC-2021-0001]
Sunshine Act Meetings
TIME AND DATE: Weeks of June 14, 21, 28, July 5, 12, 19, 2021.
PLACE: Commissioners' Conference Room, 11555 Rockville Pike, Rockville,
Maryland.
STATUS: Public.
MATTERS TO BE CONSIDERED:
[[Page 31348]]
Week of June 14, 2021
There are no meetings scheduled for the week of June 14, 2021.
Week of June 21, 2021--Tentative
Tuesday, June 22, 2021
9:00 a.m. Briefing on Transformation at the NRC--Midyear Review (Public
Meeting); (Contact: Maria Arribas-Colon: 301-415-6026)
Additional Information: Due to COVID-19, there will be no physical
public attendance. The public is invited to attend the Commission's
meeting live by webcast at the Web address--https://video.nrc.gov/.
Week of June 28, 2021--Tentative
There are no meetings scheduled for the week of June 28, 2021.
Week of July 5, 2021--Tentative
There are no meetings scheduled for the week of July 5, 2021.
Week of July 12, 2021--Tentative
There are no meetings scheduled for the week of July 12, 2021.
Week of July 19, 2021--Tentative
There are no meetings scheduled for the week of July 19, 2021.
CONTACT PERSON FOR MORE INFORMATION: For more information or to verify
the status of meetings, contact Wesley Held at 301-287-3591 or via
email at [email protected]. The schedule for Commission meetings is
subject to change on short notice.
The NRC Commission Meeting Schedule can be found on the internet
at: https://www.nrc.gov/public-involve/public-meetings/schedule.html.
The NRC provides reasonable accommodation to individuals with
disabilities where appropriate. If you need a reasonable accommodation
to participate in these public meetings or need this meeting notice or
the transcript or other information from the public meetings in another
format (e.g., braille, large print), please notify Anne Silk, NRC
Disability Program Specialist, at 301-287-0745, by videophone at 240-
428-3217, or by email at [email protected]. Determinations on requests
for reasonable accommodation will be made on a case-by-case basis.
Members of the public may request to receive this information
electronically. If you would like to be added to the distribution,
please contact the Nuclear Regulatory Commission, Office of the
Secretary, Washington, DC 20555, at 301-415-1969, or by email at
[email protected] or [email protected].
The NRC is holding the meetings under the authority of the
Government in the Sunshine Act, 5 U.S.C. 552b.
Dated: June 9, 2021.
For the Nuclear Regulatory Commission.
Wesley W. Held,
Policy Coordinator, Office of the Secretary.
[FR Doc. 2021-12449 Filed 6-9-21; 4:15 pm]
BILLING CODE 7590-01-P